Skip to main content
SHANGHAI MICROPORT EP MEDTECH CO., LTD. logo

SHANGHAI MICROPORT EP MEDTECH CO., LTD. — Investor Relations & Filings

Ticker · 688351 ISIN · CNE100005PG9 Shanghai Stock Exchange Manufacturing
Filings indexed 362 across all filing types
Latest filing 2026-03-30 Notice of Dividend Amou…
Country CN China
Listing Shanghai Stock Exchange 688351

About SHANGHAI MICROPORT EP MEDTECH CO., LTD.

https://www.everpace.com/

SHANGHAI MICROPORT EP MEDTECH CO., LTD. focuses on the research, development, and commercialization of medical devices for cardiac electrophysiology. The company provides a comprehensive suite of products for the diagnosis and treatment of cardiac arrhythmias, including 3D cardiac mapping systems, diagnostic catheters, and radiofrequency ablation catheters. Its core technology, the Columbus 3D EP Navigation System, enables precise localization and visualization of catheters within the heart. The product line also encompasses irrigation pumps and ablation generators designed to support minimally invasive procedures. The company aims to deliver integrated solutions that improve clinical outcomes for patients with rhythm disorders through advanced mapping and therapeutic technologies.

Recent filings

Filing Released Lang Actions
关于2025年度利润分配预案的公告
Notice of Dividend Amount Classification · 95% confidence The document is an announcement from Shanghai MicroPort EP MedTech Co., Ltd. regarding the 2025 annual profit distribution plan. It details the proposed cash dividend per share, total dividend amount, and the rationale behind the dividend policy, including references to audited net profit figures and retained earnings. The document also describes the board and independent directors' approval of the plan and mentions that the plan will be submitted to the shareholders' meeting for approval. The content focuses on dividend distribution details rather than presenting full financial statements or comprehensive financial performance data. The document length is 3966 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of Notice of Dividend Amount (DIV), which covers announcements of dividend amounts, payment dates, and related details for shareholders.
2026-03-30 Chinese
2025年度内部控制评价报告
Audit Report / Information Classification · 95% confidence The document is titled as an "Internal Control Evaluation Report" for the year 2025 by Shanghai MicroPort EP MedTech Co., Ltd. It discusses the evaluation of the company's internal control effectiveness as of December 31, 2025, including financial and non-financial internal control defects, their identification standards, and remediation status. The content is focused on internal control evaluation rather than full financial statements or audit opinions alone. The document length is 4175 characters, which is relatively short but contains substantive evaluation content rather than just an announcement or certification. This type of report is typically classified as an Audit Report / Information (AR) because it deals with internal control evaluation results and related audit opinions, distinct from a full Annual Report (10-K) or Interim Report (IR). It is not a Regulatory Filing (RNS) or Report Publication Announcement (RPA) since it contains detailed evaluation content, not just a notice or certification. Therefore, the best fit is AR (Audit Report / Information). FY 2025
2026-03-30 Chinese
2025年度会计师事务所的履职情况评估报告
Audit Report / Information Classification · 95% confidence The document is titled as an evaluation report on the performance of the accounting firm for the fiscal year 2025, mentioning audit procedures, independence, and communication with the audit committee and management. It references auditing standards and the audit of the company's 2025 financial report and internal controls. The content focuses on the audit firm's duties and results rather than the full annual report itself. The document length is short (669 characters), and it is a standalone audit evaluation report rather than a full annual report or financial statement. Therefore, it fits the category of an Audit Report / Information (AR). FY 2025
2026-03-30 Chinese
董事、高级管理人员薪酬管理制度
Remuneration Information Classification · 95% confidence The document is titled '董事、高级管理人员薪酬管理制度' which translates to 'Remuneration Management System for Directors and Senior Management'. It details the principles, management, standards, adjustments, and policies related to the compensation of directors and senior executives of the company. There is no financial data, earnings information, or report publication mentioned. The content is focused on remuneration policies and governance related to compensation. According to the filing definitions, this matches the description of 'Remuneration Information' (DEF 14A), which covers reports detailing compensation for top executives and directors.
2026-03-30 Chinese
2025年年度报告
Annual Report Classification · 100% confidence The document is titled "上海微创电生理医疗科技股份有限公司2025 年年度报告" which translates to "Shanghai MicroPort EP Medtech Co., Ltd. 2025 Annual Report." It contains detailed sections typical of an annual report, including company overview, financial data for multiple years, management discussion and analysis, governance, risk factors, and audited financial statements. The document length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. It includes audited financial data, management analysis, and comprehensive disclosures. Therefore, this document fits the definition of an Annual Report (10-K). FY 2025
2026-03-30 Chinese
关于上海微创电生理医疗科技股份有限公司2025年度募集资金存放、管理与使用情况专项报告的鉴证报告
Audit Report / Information Classification · 85% confidence The document is a “鉴证报告” (CPA assurance report) on the company’s 2025 annual raised funds storage, management, and usage (“募集资金专项报告的鉴证报告”). It is a standalone audit/assurance report on a specific financial item (raised funds), not a full annual or interim report, not merely announcement of report publication, and contains the auditor’s responsibility, scope, and opinion. This matches the standalone audit report category (AR). FY 2025
2026-03-30 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.